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Background: Astrocytoma are known to have altered glutamate machinery that results in the release of large
amounts of glutamate into the extracellular space but the precise role of glutamate in favoring cancer processes
has not yet been fully established. Several studies suggested that glutamate might provoke active killing of neurons
thereby producing space for cancer cells to proliferate and migrate. Previously, we observed that calcium promotes
disassembly of integrin-containing focal adhesions in astrocytoma, thus providing a link between calcium signaling
and cell migration. The aim of this study was to determine how calcium signaling and glutamate transmission
cooperate to promote enhanced astrocytoma migration.
Methods: The wound-healing model was used to assay migration of human U87MG astrocytoma cells and allowed
to monitor calcium signaling during the migration process. The effect of glutamate on calcium signaling was
evaluated together with the amount of glutamate released by astrocytoma during cell migration.
Results: We observed that glutamate stimulates motility in serum-starved cells, whereas in the presence of serum,
inhibitors of glutamate receptors reduce migration. Migration speed was also reduced in presence of an intracellular
calcium chelator. During migration, cells displayed spontaneous Ca2+ transients. L-THA, an inhibitor of glutamate
re-uptake increased the frequency of Ca2+ oscillations in oscillating cells and induced Ca2+ oscillations in quiescent
cells. The frequency of migration-associated Ca2+ oscillations was reduced by prior incubation with glutamate
receptor antagonists or with an anti-β1 integrin antibody. Application of glutamate induced increases in internal free
Ca2+ concentration ([Ca2+]i). Finally we found that compounds known to increase [Ca
2+]i in astrocytomas such as
thapsigagin, ionomycin or the metabotropic glutamate receptor agonist t-ACPD, are able to induce glutamate release.
Conclusion: Our data demonstrate that glutamate increases migration speed in astrocytoma cells via enhancement
of migration-associated Ca2+ oscillations that in turn induce glutamate secretion via an autocrine mechanism. Thus,
glutamate receptors are further validated as potential targets for astrocytoma cancer therapy.
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Primary brain neoplasm derived from glial cells account
for more than 40% of all brain tumors. Among gliomas,
astrocytomas represent the most common type of glial
tumors and are generally associated with poor prognosis
as these tumor cells often diffusely infiltrate neighboring
brain structures by migrating along defined pathways
such as blood vessels or myelinated nerves. This charac-
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unless otherwise stated.the time the primary tumor can be removed, secondary
tumors may have already invaded the surrounding paren-
chyma. Hence, the aggressiveness of astrocytomas could
be decreased by inhibiting cell migration, thereby confin-
ing the tumor in its original location.
Migration is a cellular process by which motile cells
interact with different adhesion molecules presented by
other cell types and extracellular matrix. Binding of
adhesion proteins to their receptors generates signals
that regulate cell proliferation and migration. A change
in calcium homeostasis has been shown to represent one
of the major intracellular signals implicated in the multiple
and highly coordinated molecular events necessary tol Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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lar Ca2+ modulate neuronal migration of growth cones
[1,2] and cerebellar granule cells [3]. Changes in intracel-
lular Ca2+ have been reported to be responsible for persist-
ent forward migration of neutrophils [4]. Several signaling
pathways can be implicated in Ca2+ signaling observed
during migration, including those mediated by adhesion
receptors of the integrin family and those mediated by
serum which could promote activation of the MAP kinase
cascade [5,6]. Hence, in mouse fibroblasts, integrin
engagement leads to phosphorylation of FAK and the
subsequent conformation change promotes direct activa-
tion of PLC-γ1 with the FAK autophosphorylation site
Tyr-397, resulting in the generation of IP3 and release
of Ca2+ from internal Ca2+ stores [7]. Previously, we
demonstrated that in astroctytoma, increases in [Ca2+]i
are associated with increased phosphorylation of FAK at
Tyr-397 [8].
The initial promoter of the Ca2+ signal appears to be cell
type specific. In fish keratinocytes, integrin-dependent
cell motion stimulates stretch-activated Ca2+-channels
[9] whereas in arteriolar smooth muscle, integrin ligands
modulate L-type Ca2+ channels [10]. In the developing
brain, migration of immature neurons to their final
destination is correlated with the expression of both
N-type Ca2+ channels and glutamate receptors. More-
over, the rate of movement of granule cells appears to
be controlled by the activity of NMDA receptors [11].
In mice, glutamate serves as a chemoattractant for neu-
rons in the developing cortex, signaling cells to migrate
into the cortical plate via NMDA receptor activation [12].
In astrocytes, pharmacological blockade of NMDA recep-
tors inhibits PSA-NCAM biosynthesis and dramatically
diminishes cell migration from neurohypophyseal explants
[13]. Nevertheless, the precise role of glutamate in
mediating cell migration is not well understood, espe-
cially for glioma cells. For example, it has been de-
scribed that glioma release large amounts of glutamate
via both compromised glutamate transporters [14] and
the cystine-glutamate exchange system Xc− [15]. The
pathophysiological significance of elevated glutamate in
the extracellular space has not been fully investigated, al-
though it has been suggested that it might promote active
neuronal cell death, thereby creating space for the growing
tumor to expand [16] and enhancing glioma migration via
activation of Ca2+-permeant AMPA receptors [17].
In this study, we investigated the role of glutamate in
favoring glioma cell migration. We demonstrate that
the human astrocytoma cell line U87MG is able to
release glutamate in the extracellular space which in
turn, activates glutamate receptors in an autocrine/
paracrine manner, thus leading to calcium signaling
involved in both cell migration and enhanced glutam-
ate release.Results
Glutamate-enhanced migration of astrocytoma cells
Initially, using the wound-healing model of cell migra-
tion, we measured the migration speed of U87MG cells
plated on matrigel-coated dishes. In the presence of 10%
FCS the rate of migration was 470 ± 3 μm/24 h and 251 ±
4 μm/24 h in the absence of serum. Incubating the cells
with the cell permeant Ca2+ chelator BAPTA/AM reduced
serum-dependent migration while serum-independent
migration was unchanged. This indicates the existence of
a Ca2+-dependent migration process mediated at least
in part by serum. In the absence of serum, addition of
glutamate increased the rate of migration by 44% to
362 ± 3 μm/24 h, whereas in the presence of serum the
rate of migration was unchanged by glutamate addition
(Figure 1). Taken together, this suggests a role for glu-
tamate and Ca2+ signaling in mediating cell motility.
The decrease in migration observed for BAPTA-loaded
cells likely involves a regulatory mechanism controlling
the attachment of integrins to the substratum. We
therefore compared the distribution pattern of β1 integ-
rins in migrating cells loaded or not with BAPTA. Buff-
ering Ca2+ lead to the accumulation of β1 integrins at
the tail of the cell (Figure 1C). Moreover, patches of
integrin-containing structures were found at the rear of
the cell, consistent with “ripping release”, as the cell
moved forward. This is consistent with changes in Ca2+
being necessary to promote the recycling of β1 integrins
from the tail of the cell.Migration of astrocytoma cells is associated with
intracellular calcium oscillations
The above results prompted us to further analyze the
role of Ca2+ in migration. To do so, we used confocal
imaging of intracellular Ca2+ in single migrating cells.
In the presence of serum, 36% of cells displayed intra-
cellular Ca2+ oscillations at varying frequencies during
the 15 min observation period, whereas no spontaneous
variations in Ca2+ were detected in the absence of
serum (Figure 2A, B). To assess whether calcium oscil-
lations were associated with migration, we tested a
function-blocking antibody directed against β1 integ-
rins, one of the major integrins present in astrocytoma
cells. For this purpose, cells were incubated with the
anti-β1 antibody P4C10 prior to calcium measurements.
In the presence of anti-β1 antibody, a large decrease in
the percentage of cells displaying Ca2+ transients was
observed, up to 96%, consistent with an essential role of
integrin engagement in the generation of Ca2+ oscilla-
tions (Figure 2C). Of note, this antibody also signifi-
cantly decreased the rate of migration of astrocytomas
in the presence of serum by 73%, with a mean value of
172 ± 4 μm/24 h (n = 4).
Figure 1 Glutamate increases motility in astrocytoma cells. A: Representative field showing U-87MG cells plated on Matrigel-coated dishes
after 24 hours of migration in a wound healing model of migration (the white line indicates the border of the lesion). B: The speed of migration
of U-87MG cells plated on matrigel-coated dishes was measured 24 h after lesion. The presence of 10% fetal calf serum (FCS) in the culture
medium increases the rate of migration by 51%. Serum-dependent migration is reduced by 55% when the cells were first loaded for 30 minutes
with 20 μM BAPTA-AM to chelate intracellular Ca2+. Glutamate increased serum-independent migration while serum-dependent migration was left
unchanged. Data are mean ± SEM; n = 4 independent experiments with 120 to 240 cells analyzed per condition; ***p < 0.001. C: Cells loaded or not
with 20 μM BAPTA, were allowed to migrate on Matrigel-coated glass coverslips and then immunostained with the anti-β1 integrin antibody. White
arrows indicate the cellular tail and yellow arrows, patches of β1 integrin. Scale bar, 20 μm. The number of patches of β1 integrin-containing structures
found at the rear of the cell was quantified in control and BAPTA-loaded cells. Data are mean ± SEM of 3 independent experiments with 4 fields
analyzed per experiment.
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astrocytoma cells
It is well described that gliomas and astrocytomas re-
lease large amounts of glutamate in the medium as com-
pared to non cancer cells [14]. Moreover, it has been
previously shown that glioma invasion may be promoted
via an autocrine glutamate signaling loop [17]. The re-
lease of glutamate by glioma/astrocytoma cells could be
both Ca2+-dependent and Ca2+-independent. Therefore,
as U87MG cell migration is associated with calcium
oscillations and augmented in the presence of glutamate,
we tested whether compounds known to increase [Ca2+]i
were able to induce release of glutamate from U87MG
cells. For this purpose, we used an enzymatic assay to
continuously monitor the release of glutamate in migrat-
ing cells plated on matrigel-coated coverslips in order to
keep the same experimental conditions as those used to
measure the speed of migration and changes in [Ca2+]i.
We first used two compounds, thapsigagin and ionomycin,
known to promote large increases in [Ca2+]i in these cells
[18]. As shown in Figure 3, both thapsigargin and ionomy-
cin were able to produce glutamate release. Moreover,t-ACPD, an agonist of metabotropic glutamate receptors
which has been shown to provoke increases in [Ca2+]i in
astrocytes [19,20] also induced glutamate release. On the
other hand, we were unable to observed glutamate release
using specific agonists of NMDA and AMPA/kainate glu-
tamate receptor subtypes (data not shown).
Glutamate increases intracellular Ca2+ levels
As most glutamate receptors are known to alter calcium
homeostasis, we designed experiments to test whether
glutamate was involved in migration-associated Ca2+
oscillations using Fura-2 imaging of intracellular Ca2+ in
single migrating cells. Addition of glutamate (1 μM-
1 mM) in replacement of serum did not mimic the effect
of serum as in the majority of the cells, no oscillation of
[Ca2+]i could be detected during the migration process
(data not shown). Nevertheless, addition of 300 μM
glutamate produced a sharp increase in [Ca2+]i. In 85%
of the cells, the increase in [Ca2+]i resulted in a single
transient of Ca2+ whereas in the other 15%, oscillations
of small amplitude were detected following the initial
response (Figure 4A). The increase in [Ca2+]i was dose-
Figure 2 Migrating astrocytoma cells exhibit serum-dependent intracellular Ca2+ oscillations at varying frequencies. A: Cells plated on
Matrigel-coated glass-coverslips were loaded with Oregon green and observed using a confocal microscope. Representative traces of individual
cells show a varying number of spontaneous intracellular Ca2+ transients. Cells were grouped according to the number of intracellular Ca2+ transients
displayed during the 15 minutes acquisition period. B: The percentage of cells displaying 0, 1–9, 10–19 and >20 intracellular Ca2+ transients during
15 minutes, in the presence or absence of 10% FCS. C: The percentage intracellular Ca2+ transients during 15 minutes, in the presence or absence
of the functional antibody P4C10 directed against β1 integrins. Data are mean ± SEM of 4 independent experiments, n indicate the number of cells
analyzed per conditions.
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increase of 210 ± 26 nM Ca2+ (Figure 4B).
Glutamate reuptake inhibitor induces increased
migration-associated Ca2+ oscillations
Because addition of glutamate in the absence of serum
did not induce Ca2+ oscillations comparable to those
observed in the presence of serum, we tested whether
glutamate could enhance serum-mediated Ca2+ oscilla-
tions. As it is difficult to estimate the concentration of
glutamate present in the medium, we chose to increaseFigure 3 Ca2+ mobilizing agents induced glutamate release in
astrocytoma cells. Fluorescence traces representing glutamate release
elicited by vehicle (far left) thapsigargin (left), an inhibitor of the
endoplasmic reticulum Ca2+ ATPase, ionomycin (right), a Ca2+ ionophore,
and t-ACPD (far right), a selective metabotropic glutamate receptor
agonist. The traces are representative for 4–6 independent experiments.the concentration of glutamate in the extracellular medium
by inhibiting the reuptake of glutamate. In agreement with
our previous result, in the presence of serum, 36% of
the cells displayed intracellular Ca2+ oscillations at vary-
ing frequencies during the 15 min observation period.
Addition of 100 μM L (−)-threo-3-hydroxyaspartic acid,
a potent inhibitor of both glial and neuronal uptake of
glutamate [21] produced a two-fold increase in the fre-
quency of Ca2+ oscillations. Analyzing in further detail
the complex pattern of behavior of L-THA-treated cells,
we observed that in 30% of the cells, L-THA had no
effect whereas in 39%, L-THA caused an increase in
Ca2+ oscillation frequency (Figure 5A) and in the
remaining 31%, L-THA initiated oscillatory Ca2+ behav-
ior in cells which did not display spontaneous variations
of [Ca2+]i before addition of the compound (Figure 5B).
Taken together, these results suggest that glutamate
present in the serum and/or released by the cells is able
to alter Ca2+ homeostasis, thereby contributing to en-
hanced migration.
Glutamate antagonists reduce migration and
migration-associated Ca2+ oscillations
As glutamate increases cell migration and Ca2+ oscilla-
tion frequency, we tested whether the serum-dependent
Figure 4 Glutamate-induced increase in [Ca2+]i in astrocytoma
cells. A: Quantification of changes in [Ca2+]i as measured
microfluorimetrically in Fura-2 loaded cells. Typical individual
responses observed after addition of 300 μM glutamate are
shown. In a large number of cells, glutamate elicited single Ca2+
spike while a second spike can be observed in 10-20% of the cells
analyzed. B: Glutamate induced a concentration-dependent increase in
[Ca2+]i. Data are mean ± SEM of 4 independent experiments.
Figure 5 Inhibition of glutamate reuptake induced increase in
Ca2+ oscillations frequency. Fluo-3 loaded cells were allowed to
migrate on Matrigel-coated glass coverslips and changes in fluorescence
were measured at 522 nm using confocal microscopy before and
after addition of 100 μM L-THA. Top: Typical individual response of
spontaneous Ca2+ oscillations is presented. Note the increase in
spontaneous Ca2+ oscillations frequency after addition of L-THA.
Bottom: In non oscillating, quiescent cells, addition of L-THA induced
Ca2+ oscillations as measured by changes in fluo-3 fluorescence. Data
are mean ± SEM of 4 independent experiments with 67 cells analyzed
per condition.
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in part by glutamate acting at glutamate receptors.
Selective antagonists at NMDA receptors, MK801 [22],
kainate receptor, CNQX [23] and a large spectrum
antagonist at metabotropic receptor, AP3 [24] were
added in the culture medium supplemented or not
with 10% serum after the lesion was achieved. As
shown in Figure 6, all antagonists reduced significantly
serum-dependent migration. Migration was reduced by
24% in the presence of 10 μM MK801, 53% in the pres-
ence of CNQX and 85% in the presence of AP3. On the
other hand, all three compounds were without effect
on the serum-independent component of migration.
This is consistent with glutamate receptors being
involved in serum-mediated migration. Next, we deter-
mined which type of glutamate receptor was involved
in the oscillations of [Ca2+]i observed during migra-
tion. For this purpose, U87MG cells displaying oscil-
latory behavior were incubated for 30 min with
antagonists of various glutamate receptor subtypes and
the numbers of Ca2+ spikes were compared before and
after treatment. Addition of 10 μM MK801 slightly butsignificantly reduced the number of Ca2+ spikes. In
contrast, addition of 10 μM CNQX resulted in a 60%
inhibition of the number of Ca2+ spikes and 100 μM
AP3 caused a 78% decrease in Ca2+ oscillation fre-
quency (Figure 7). The order of potency of these com-
pounds is in agreement with their respective abilities
to inhibit serum-mediated migration and highlights
the close relationship existing between migration and
Ca2+ oscillation behavior in these cells [8,25].
Discussion
In this study, we have demonstrated that glutamate
released by human astrocytoma cells contributes to
enhanced migration by a mechanism involving glutamate-
associated Ca2+ oscillations. Indeed, antagonists of
glutamate receptors inhibit both cell migration and
migration-associated Ca2+ oscillations while glutamate
itself stimulates migration under serum deprivation.
Moreover, the glutamate reuptake inhibitor L-THA in-
creases the frequency of Ca2+ oscillations and induces
Figure 7 Glutamate antagonists reduced spontaneous Ca2+
oscillations observed during the migration process. Typical
individual responses of spontaneous Ca2+ oscillations before and
after addition of glutamate antagonists are presented. In the
presence of the ionotropic NMDA glutamate receptor antagonist
MK801 (top), or ionotropic AMPA/kainate glutamate receptor
antagonist CNQX (middle), or metabotropic glutamate receptor
antagonist AP3 (bottom), the frequencies of Ca2+ oscillations were
reduced. Insets: Data are mean ± SEM of the number of Ca2+ spikes
displayed during a 15 min observation period from 3 to 7
independent experiments with 30 to 67 cells analyzed per condition,
**p < 0.005, ***p < 0.0001.
Figure 6 Glutamate antagonists reduced astrocytoma cell
migration. In the absence of serum, glutamate antagonists had no
effect on the speed of migration while in the presence of serum,
migration was significantly reduced, the major effect being observed
using AP3 an antagonist at metabotropic glutamate receptor. Data
are mean ± SEM; n = 4 independent experiments with 50 to 240 cells
analyzed per condition; ***p < 0.001.
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correlated with the inhibitory action of the Ca2+ chela-
tor BAPTA on the migration of these cells.
Ca2+-dependent migration was first demonstrated in
neutrophils where the speed of migration and persistent
forward motion were correlated with intracellular Ca2+
levels [26]. In cerebellar microexplant cultures, while a
global increase in intracellular Ca2+ was not correlated
with cell mobility, it was rather found that the frequency
and amplitude of Ca2+ fluctuations control the rate of
migration of granule cells [3]. Moreover, granule cells
start their radial migration only after the expression of
N-type Ca2+ channels and glutamate receptors on the
plasmalemmal surface [27] supporting the idea that glu-
tamate receptors associated with Ca2+ signaling may be
a key component of cellular migration. Similarly, we re-
ported that the migration of smooth muscle cells and
U87MG cells were dependent upon oscillations of intra-
cellular Ca2+ [18,28]. The role of glutamate and Ca2+ in
regulating proliferation and migration of neurons during
development is now well recognized but little is known
concerning whether glutamate alters proliferation and
migration of tumor cells. Several studies have shown
that glutamate antagonists limit tumor growth of various
human tumor cells, including astrocytoma [29,30]. The
mechanisms implicated in this anti-cancer effect involve
both a decrease in tumor cell proliferation and a reduc-
tion of cell motility. Interestingly, the anti-proliferative
effect of glutamate antagonists was Ca2+ dependent and
resulted from decreased cell division and increased cell
death. Nevertheless, the molecular events involved in
the reduction of tumor cell locomotion and invasivenesshave not been described. Our study demonstrates that
glutamate antagonists limit migration of astrocytoma
cells by a mechanism involving a reduction in Ca2+
signaling, as found for neuronal progenitors during
embryogenesis [3]. Taken together, these data suggest
that glutamate antagonists possess anti-cancer poten-
tial because they may promote both anti-proliferative
and anti-motility effects.
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is able to reduce cell motility is an interesting question.
Calcium oscillations are associated with different pro-
cesses crucial for cell invasion like cell polarization [31],
focal adhesion turnover [8] or regulation of metallopro-
teinases [32]. Many reports have shown that Ca2+ can
alter the affinity between adhesion receptors and their
specific extracellular ligands on the extracellular matrix
[33-35] thereby providing a means to regulate migration.
Indeed, in the presence of an intracellular Ca2+ chelator
such as BAPTA, both human smooth muscle cells [28]
and astrocytoma [8] have reduced migration. The un-
derlying mechanisms may involve altered recycling of
adhesion proteins [36] or altered disassembly of focal
adhesion sites [25]. This may be due to reduced activities
of Ca2+-dependent proteases implicated in focal adhe-
sion protein degradation of for example, calpain [37-39]
or calcineurin [40]. One of the major proteins involved
in focal adhesion recycling during migration is FAK. Re-
duced cell motility and enhanced focal adhesion contact
formation has been shown in cells from FAK-deficient
mice [41]. It is now well accepted that activation of FAK
promotes migration whereas inhibition of FAK or altered
FAK phosphorylation decrease migration [42-46]. Sev-
eral reports point out the role of glutamate receptors in
the activation of FAK in a Ca2+ dependent manner. For
example, glutamate and specific agonists of ionotropic
and metabotropic glutamate receptors stimulate phos-
phorylation of FAK in hippocampal slices or cortical
synaptosomes [47]. In high-grade glioma, AMPA recep-
tors promotes perivascular invasion via integrins and FAK
activation [48]. Moreover, glutamate stimulates phospho-
lipase C and phosphorylation of FAK in CHO cells ex-
pressing mGluR1 receptors. Phosphorylation of FAK was
reduced by PLC inhibitors or by depletion of intracellular
Ca2+, consistent with a link between mGluR1 receptors,
Ca2+ and FAK activation [49]. In our study, the respective
order of potency of glutamate antagonists suggests that
metabotropic glutamate receptors are the main receptor
implicated in the Ca2+-dependent migration process ob-
served in astrocytoma cells. This is not surprising in view
of the role of mGluR1 in FAK activation, the major role of
metabotropic glutamate receptors in astrocytes and the
pattern of Ca2+ oscillations observed in U87MG cells
which is consistent with activation of mGluR1 receptors.
Next, the question arises as to know which pool of
glutamate is responsible for the enhanced migration
observed in the presence of glutamate. Because migra-
tion and Ca2+ oscillatory behavior of these cells were
dependent upon serum, it is possible that glutamate
present in the serum is sufficient to account for these
effects. Indeed, addition of 10% FCS in culture medium
or in PBS produced a large increase in NADPH fluor-
escence due to formation of α-ketoglutarate, consistentwith the presence of glutamate in FCS (not shown). In
the presence of 10% FCS, addition of glutamate did not
further enhance migration (Figure 2). Since the Ca2+
oscillation pattern observed during migration was
quite diverse, this suggests that glutamate concentra-
tion in the cellular environment is closely regulated,
probably involving controlled release and/or reuptake
of glutamate. Indeed, in the presence of a glutamate
reuptake inhibitor, the Ca2+ oscillation frequency of
our cells was increased 2-fold.
The mechanism responsible for glutamate release from
astrocytes has been the subject of controversy for some
time. Evidence for both Ca2+-dependent and -independent
mechanisms has been reported. The Ca2+-dependent
mechanism is an exocytotic process similar to that ob-
served in neurons [50,51], whereas the Ca2+-independant
mechanism may involve swelling-dependent mechanisms
[52], alteration or reversion of glutamate transporters
[15,16,53] and up-regulation of the cystine-glutamate
exchange system Xc− [15,17]. Ca2+-dependent release of
glutamate in astrocytes represents a major pathway for
intercellular communication. For example, elevation of
intracellular Ca2+ in astrocytes was both necessary and
sufficient to induce an increase in miniature postsynaptic
currents in cultured hippocampal neurons, an effect pre-
vented by the NMDA receptor antagonist AP5, consistent
with release of glutamate from astrocytes [51]. Extracellu-
lar waves of glutamate were imaged during Ca2+ signaling
in cultured astrocytes [54]. Finally, glutamate mediates
calcium oscillations in astrocytes leading to the release
of other transmitters like prostaglandin [55]. In our
study, compounds that mobilize intracellular calcium
store, like thapsigargin or t-ACPD, an agonist of the
metabotropic glutamate receptors, stimulate glutamate
release (Figure 3). This agrees with previous studies
showing that Ca2+-dependent release of glutamate in-
volves intracellular Ca2+ stores in astrocytes [56,57] and
with the expression of metabotropic receptors in both
astrocytes and astrocytomas [58,59]. Of note, in astro-
cytomas, glutamate release and reuptake mechanisms
appear deeply altered. For example, although one of the
major role of astrocytes is to protect neuron from an
excess of glutamate via high capacity reuptake systems
[60], astrocytomas release large amounts of glutamate
which result in elevated external glutamate concetra-
tions, up to 100 μM [14]. In our cells, the glutamate
reuptake inhibitor L-THA enhanced calcium oscilla-
tions (Figure 5). As L-THA is a substrate inhibitor and
therefore, being transported by the glutamate trans-
porter in place of glutamate [61], the increase in Ca2+
signaling observe upon L-THA addition indicates that
glutamate transporters are at least partially functional in
U87MG cells. The ability of L-THA to either increase the
frequency of Ca2+ oscillations or to induce Ca2+ oscillations
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of glutamate transporters is responsible for Ca2+-medi-
ated migration of astrocytoma cells.
Conclusion
Our study uncovers an autocrine glutamate signaling loop
whereby altered glutamate reuptake leads to enhanced
glutamate release from astrocytoma cells and subsequent
activation of glutamate receptors, particularly the metabo-
tropic subtypes. This in turn activates calcium signaling
further promoting glutamate release. Finally, Ca2+ oscilla-
tions induce FAK phosphorylation and focal adhesion dis-
assembly as we already reported in this cell line [8], thus
leading to enhanced migration.
Methods
Materials
Cell culture medium (EMEM), fetal calf serum (FCS),
HEPES, L-glutamine, penicillin, streptomycin, gentamycin
and trypsin-EDTA solution (0.5 g/l trypsin/0.2 g/l EDTA)
were from Gibco. Glutamate, CNQX, AP3 MK801 and
L-(−)-threo-3-Hydroxyaspartic acid were from Tocris.
Glutamate deshydrogenase and NADP+ were from Sigma.
Oregon Green 488 BAPTA-1 acetoxylmethylester (AM),
Fura-2/AM, BAPTA/AM and Pluronic acid F-127 were
from Molecular Probes.
Cell culture
The human astrocytoma cell line U87MG was obtained
from the American Type Culture Collection. Cells were
maintained in 5% CO2 in air at 37°C in a humidified incu-
bator on type I collagen (0.06 mg/ml) -coated plastic
dishes in EMEM supplemented with 10% heat-inactivated
FCS, 0.6 mg/ml glutamine, 200 IU/ml penicillin, 200 IU/ml
streptomycin and 0.1 mg/ml gentamycin.
Migration assay
U-87MG were seeded onto 35 mm diameter Petri dishes
coated with Matrigel (178 μg/ml) and grown to conflu-
ence in a 37°C incubator gassed with 5% CO2 in air.
After 24 h of serum starvation, a rectangular lesion was
created using a cell scraper and cells were rinsed 3 times
with culture medium containing or not 10% FCS. The
cells were then incubated with the respective experimen-
tal medium supplemented or not with the compound to
be tested. After 24 h of migration, 3 randomly selected
fields at the lesion border were acquired using a 10x
phase objective on an inverted microscope (Olympus
IMT2) equipped with a CCD camera (Panasonic). In
each field, the distance between the margin of the lesion
and the most distant point on migrating cells was ana-
lyzed for the 10 most mobile cells. Control experiments
were made in presence of vehicle, typically water or
DMSO at ≤ 0.01%. Analysis was made using the ImageTool program (University of Texas Health Science Cen-
ter at San Antonio; available by FTP from maxrad6.
uthscsa.edu). For experiments with BAPTA/AM, cells
were loaded for 45 min with 20 μM BAPTA/AM and
0.03% Pluronic acid F-127 in a 37°C incubator gassed
with 5% CO2 in air prior to the creation of lesions and
washing.
Cytosolic free calcium measurements
For intracellular calcium measurements during migra-
tion, cells were cultured at subconfluence on Petri dishes
in which a 2 cm diameter hole had been cut in the base
and replaced by a thin (0.07 mm) glass coverslip coated
with Matrigel. Experiments were performed 48 h or 72 h
after plating. Cells were incubated for 45 min with the
fluorescent Ca2+ indicator Oregon Green 488 BAPTA-1
acetoxylmethylester (5 μM) in culture medium contain-
ing 0.03% Pluronic acid F-127 in a 37°C incubator gassed
with 5% CO2 in air. Cells were then washed twice with
an external solution (in mM: 140 NaCl, 5 KCl, 2 CaCl2,
2 MgCl2, 10 HEPES and 11 glucose, pH 7.4) before Ca
2+
measurements. Imaging was done at 30°C in external
solution, with or without the compounds to be tested,
using a Bio-Rad MRC-1024 laser-scanning confocal sys-
tem and an inverted microscope (Nikon Eclipse) using a
40 × oil-immersion epifluorescence objective (n.a. 1.4,
Nikon). Emitted fluorescence was measured at 535 ±
10 nm in response to 488 nm excitation from a krypton/
argon laser, with images being usually acquired at 1 s
intervals during a 15 min period. In experiments meas-
uring intracellular calcium concentrations, cells were
incubated for 30 min at 37°C in a Ringer containing 5 μM
Fura-2/acetoxylmethylester (Fura-2/AM). Cells were then
washed for 15 min at 37°C with Ringer solution. Digital
imaging was performed at room temperature using an
IMSTAR (Paris, France) imaging system. Small groups of
dispersed cells were viewed using an inverted microscope
(Nikon Diaphot, Tokyo, Japan) and an UV-fluor 20x
objective (n.a. 0.75, Nikon). Fura-2 fluorescence was
excited alternately at 340 and 380 nm, using bandpass
filters (±10 nm, Nikon) and a 100 W mercury lamp
(HBO, Osram). Emitted fluorescence was bandpass
filtered at 510 ± 20 nm (Nikon) and measured using
a Darkstar-800 CCD Camera (Photonics Sciences,
Milham, UK). Acquired images were analyzed with the
fluo 210 IMSTAR software. Ratiometric Ca2+ images
were generated at 5 s intervals, using 4 averaged im-
ages at each wavelength. After background compensa-
tion, [Ca2+]i was averaged from pixels within manually
outlined regions of interest corresponding to each cell.
[Ca2+]i values were calculated as described elsewhere
(Grynkiewicz et al., 1985). Control experiments were
made in presence of vehicle, typically water or DMSO
at ≤ 0.01%.
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Cells treated or not with 20 μM BAPTA-AM for 30 min,
were allowed to migrate for 24 h before immunostaining.
After 15 min fixation in 4% paraformaldehyde in PBS,
cells were incubated 1 h with the anti-β1 integrin anti-
body P4C10 (1/400, V/V) in PBS, and then with a
FITC-conjugated goat anti-mouse secondary antibody
(Zymed) for 1 h. Confocal images of migrating cells
were obtained as described above, with Z-series being
collected in 1 μm steps. Analysis was done after stack-
ing the first 6 images corresponding to the basal,
matrix-associated sections of the cell. The number of
patches of β1 integrin-containing structures found at
the rear of the cell was quantified in control and
BAPTA-loaded cells.Enzymatic assay of endogenous glutamate release
Confluent U-87MG cells plated on glass cover slips were
lodged in a 1 x 1 cm cuvette containing Ringer’s solution
supplemented with glutamate deshydrogenase (40 U/ml)
and 1 mM NADP+ inside a Hitachi 2000 computerized
spectrofluorimeter at 37°C under stirring. Glutamate re-
leased from the preparation was immediately oxidized
by GDH to α-ketoglutarate with formation of NADPH
and fluorescence emission at 430 nm (delay <1 s; excita-
tion at 335 nm). Release was quantified using standard
curves constructed with exogenous addition of glutam-
ate from 0.1 μM to 1 mM. Agents were added directly
in the cuvette using a microsyringe. In experiments
using BAPTA/AM, cells were first incubated for 45 min
with 20 μM BAPTA/AM and 0.03% Pluronic acid F-127
in a 37°C incubator gassed with 5% CO2 in air, then
washed twice with Ringer’s solution and placed into the
cuvette. Control experiments were made in presence of
DMSO at ≤ 0.01%.Statistical analyses
All data represent at least 3 independent experiments
and results are shown as mean ± SEM. Statistical differ-
ences between two groups were determined by Student’s
t-test. Analysis of variance (ANOVA) analysis was ap-
plied for multiple group comparison. Differences were
considered to be significant at p ≤ 0.05.
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